<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
Elaine F. Remmers(National Institutes of Health), Peter K. Gregersen(Northwell Health), Wei V. Chen(The University of Texas MD Anderson Cancer Center), Leonid Padyukov(Karolinska University Hospital), Christopher I. Amos(The University of Texas MD Anderson Cancer Center), Daniel L. Kastner(National Institutes of Health), Hye‐Soon Lee(Feinstein Institute for Medical Research), Geoffrey Hom, Annette T. Lee(Northwell Health), Timothy W. Behrens(Utrecht University), Matthew G. Booty(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Wentian Li(Feinstein Institute for Medical Research), Paul I. W. de Bakker(Broad Institute), Lars Alfredsson(University of Helsinki), Lars Klareskog(Karolinska University Hospital), Franak Batliwalla(Feinstein Institute for Medical Research), Lindsey A. Criswell(National Human Genome Research Institute), Julie Le(UC San Diego Health System), Robert M. Plenge(Broad Institute), John P. Carulli(Biogen (United States)), Seth L. Masters(Walter and Eliza Hall Institute of Medical Research), Michael F. Seldin(University of California, Davis), Robert Graham(GenProMarkers (United States))
Cited by 1,050
Related Papers
A second generation human haplotype map of over 3.1 million SNPs
|Nature|2007|4.6k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k